@entity1800 causing @entity294 is a common complication observed in lung transplant recipients. Differently from the mild and typically self-limited disease seen in immunocompetent subjects, immunocompromised @entity1 frequently have a more severe course. Norovirus and rotavirus are among the leading causes of severe @entity1902 in transplant recipients. Specific treatment is unavailable, although good supportive treatment can significantly reduce morbidity. Previous studies have suggested that oral immunoglobulins may be used for the treatment of acute @entity1800 after solid-organ transplantation. Herein, we conducted a retrospective chart review of 12 lung transplant recipients with norovirus-induced @entity1902 who were treated with oral immunoglobulins for 2 days. Eleven @entity1 were successfully treated, whereas 1 subject was only mildly improved. Four @entity1 had at least 1 recurrence. No significant adverse effects were observed. We conclude that oral immunoglobulins may be clinically useful for lung transplant recipients with norovirus-induced @entity1902 .

Clinical usefulness of oral immunoglobulins in lung transplant recipients with norovirus XXXX : a case series.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1800 :: ('MESH:D014777', 'Disease') :: ['Viral gastroenteritis', 'viral gastroenteritis'] @entity294 :: ('MESH:D003967', 'Disease') :: ['diarrhea'] @entity1902 :: ('MESH:D005759', 'Disease') :: ['gastroenteritis']
@entity1902 :: (MESH:D005759,Disease) :: ['gastroenteritis']
